In an effort to identify Otx2 targets in mouse anterior neuroectoderm we identified a gene, mShisa, which is homologous to xShisa1 that we previously reported as a head inducer in Xenopus. mShisa encodes an antagonist against both Wnt and Fgf signalings; it inhibits these signalings cell-autonomously as xShisa1 does. The mShisa expression is lost or greatly reduced in Otx2 mutant visceral endoderm, anterior mesendoderm and anterior neuroectoderm. However, mShisa mutants exhibited no defects in head development. Shisa is composed of five subfamilies, but normal head development in mShisa mutants is unlikely to be explained in terms of the compensation of mShisa deficiency by its paralogues or by known Wnt antagonists in anterior visceral endoderm and/or anterior mesendoderm.
Introduction
Otx2 plays essential roles in each step and site of mouse head development. First, Otx2 is essential to the anterior movement of distal visceral endoderm cells to form anterior visceral endoderm (Kimura et al., 2000) . A gene encoding Wnt antagonist, Dkk1, was identified as a direct target of Otx2 gene product (Otx2) in visceral endoderm (Kimura-Yoshida et al., 2005) . The Dkk1 expression is lost in Otx2 −/− mutants, and the transgenic Dkk1 expression in visceral endoderm cells restores the anterior movement of distal visceral endoderm cells in Otx2 −/− mutants. However, the transgenic Dkk1 is not sufficient to restore the development of anterior neuroectoderm. This suggests that, in anterior visceral endoderm and/or anterior mesendoderm, Otx2 targets another gene to suppress posteriorizing signals for head development. A series of antagonists against Wnt, Fgf, Nodal and BMP signalings are expressed in anterior visceral endoderm and anterior mesendoderm. However, except for Dkk1, all of them are expressed in Otx2
Otx2 is also one of the genes expressed earliest in anterior neuroectoderm induced by anterior visceral endoderm and anterior mesendoderm (Simeone et al., 1992; Ang et al., 1994) . We previously identified the AN enhancer responsible for this Otx2 expression (Kurokawa et al., 2004) . In the mutants that lack this enhancer (Otx2 ΔAN/− ), Six3-positive anterior neuroectoderm is once induced, but subsequently caudalized into Gbx2-positive posterior neuroectoderm. It is speculated that Otx2 also targets antagonists against posteriorizing signals in anterior neuroectoderm. In contrast to anterior visceral endoderm and anterior mesendoderm, however, signal antagonists known to be expressed in anterior neuroectoderm are scarce. We have made an effort to identify Otx2 targets in this tissue by a microarray analysis between embryonic day (E) 7.5 Otx2 ΔAN/+ and Otx2 ΔAN/− embryos. The analysis identified a gene, mShisa, which is homologous to xShisa1 that we previously reported as a head inducer in Xenopus (Yamamoto et al., 2005) .
xShisa1 encodes an antagonist against both Wnt and Fgf signalings; it inhibits these signalings cell-autonomously by suppressing the maturation and cell surface expression of Frizzled and Fgf receptor (Yamamoto et al., 2005) . Here we report that mShisa also encodes a cell-autonomous antagonist against Wnt and Fgf signalings. The mShisa expression is lost or greatly reduced in Otx2 −/− visceral endoderm and Otx2 ΔAN/− anterior mesendoderm and anterior neuroectoderm. However, mShisa mutants exhibited no defects in head development. Shisa consists of five subfamilies, and a series of Wnt antagonists are expressed in anterior visceral endoderm and anterior mesendoderm. Normal head development in mShisa mutants, however, is unlikely to be explained in terms of the compensation of mShisa deficiency by its paralogues or by known functionally related genes.
Materials and methods

Isolation of mShisa
Total RNAs were isolated from E7.5 or 5-8 somite stage Otx2 ΔAN/+ and Otx2 ΔAN/+ embryos, in which one allele lacks the AN enhancer and the other allele is either wild-type or null mutant (Kurokawa et al., 2004) . Five micrograms of total RNAs was subjected to the One-Cycle Target Labeling method to synthesize biotin-labeled cRNA probes. The cRNA probes were subsequently fragmented and hybridized to the GeneChip Mouse Genome 430 2.0 array (Affymetrix), according to the manufacturer's instruction. The microarray image data were generated with GeneChip Scanner3000 (Affymetrix) and analyzed with GeneChip Operating Software (GCOS). The signal intensities of each transcript on the chip were compared between Otx2 ΔAN/− and Otx2 ΔAN/+ embryos, and the transcripts with reduced signals in the Otx2 ΔAN/− embryos at both E7.5 and 5-8 somite stages
were selected for further analyses. One of these transcripts was an unknown IMAGE clone, Tmem46, which turned out to be the mouse homologue of xShisa1 we previously isolated in Xenopus (Yamamoto et al., 2005) . mShisa full-length cDNA (GenBank accession no. AB280737) was isolated from mouse E8.0-8.5 cDNA libraries (Murata et al., 2004) ; mShisa3, mShisa4 and mShisa5 (GenBank accession no. AK077061, AK039457 and AK033545, respectively) cDNAs were obtained from the FANTOM II libraries (Okazaki et al., 2001 ).
Generation of mutant mice mShisa, mShisa3, mShisa4, mShisa5 and Dkk1 mutant mice (Accession no.: CDB0044K, CDB0045K, CDB0046K, CDB0047K and CDB0030K, respectively) were generated by gene targeting in TT2 embryonic stem (ES) cells as described (Yagi et al., 1993; Murata et al., 2004) . Genomic DNA fragments were isolated by long amplification PCR with C57BL/6 BAC clones to construct targeting vectors (TV) and control vectors (CV) (Murata et al., 2004) . To disrupt mShisa, mShisa3 and mShisa4, the TV cassette used was LacZ/Neo-DTA, and the CV cassette was LacZ/Neo. To disrupt mShisa5, the lacZ gene in the LacZ/ Neo-DTA cassette was capped with an internal ribosomal entry site (IRES) (Furushima et al., 2005) . To disrupt Dkk1, the lacZ gene in LacZ/Neo-DTA and LacZ/Neo cassettes was replaced with Venus (Nagai et al., 2002) to construct TV and CV, respectively. IDs of BAC clones used, primer sequences to amplify the DNA fragments and to identify homologous recombinant ES clones, and restriction enzyme sites to which each DNA fragment was inserted in the LacZ/ Neo-DTA or LacZ/Neo cassette are described in Supplementary Tables 1 and 2 . Details of the vector construction will be provided upon request.
Three mutant mouse strains were established from independent homologous recombinant ES clones on each gene; no difference in phenotype was apparent among these mutant strains of the same gene. Chimeras were mated and mutant mice were maintained by mating with C57BL/6 mice. Southern hybridization was performed as described (Suda et al., 1999) ; genotyping of mice or embryos was routinely performed with tail, yolk sac or a part of embryonic tissue specimens by PCR using a mixture of two or three primers (Nagy et al., 2003) . In some experiments, embryos after whole-mount in situ hybridization were genotyped after the overnight treatment with protease K in PCR buffer (Martinez Barbera et al., 2000) . The sequences of primers used and size of PCR products are shown in Supplementary Table 2.
Sfrp1 mutant mice were previously generated and genotyped as described (Satoh et al., 2006) . Cerl, Cerl-2, Lefty1 and Lefty2 mutant mice were the kind gift of Dr. J.A. Belo (Instituto Gulbenkian de Ciência, Portugal) and Dr. H. Hamada (Osaka University, Japan), respectively, and genotyped as described Marques et al., 2004; Meno et al., 1998 Meno et al., , 1999 . The mutants maintained by mating with C57BL/6 mice were subjected to the generation of compound mutants with mShisa mutants.
Mice were housed in environmentally controlled rooms of the Laboratory Animal Housing Facility of the Center for Developmental Biology (CDB), RIKEN Kobe, under the Institute guidelines for animal and recombinant DNA experiments.
In situ hybridization, βGal staining and histology
Whole-mount and section in situ hybridization analyses were performed using digoxigenin-UTP-labeled (Roche) probes as described (Wilkinson, 1998; Suda et al., 2001) . Probes used were as follows: Otx2 (Matsuo et al., 1995) , Pax6 (Walther and Gruss, 1991) , Six3 (Oliver et al., 1995) and Cer1 (Belo et al., 1997) . The probe for the mShisa3 expression was a partial cDNA, and those for mShisa4 and mShisa5 expression were full-length cDNA; they were obtained from the FANTOM II library (Okazaki et al., 2001) . Dkk1 (GenBank accession no. BC050189) fulllength clone was obtained from IMAGE clone (http://image.llnl.gov).
βGal expression was determined as previously described (Kimura et al., 1997 (Kimura et al., , 2000 . E9.5 and E14.5 embryos were fixed in 4% formaldehyde and 0.2% glutaraldehyde in PBS for 5 min and 60 min, respectively. Histological analysis was performed as described (Suda et al., 2001) ; embryos were fixed with Bouin's fixative solution, serial sections were prepared at 10 μm thickness and stained with hematoxylin and eosin.
RT-PCR and Northern blot analysis
One microgram of total RNAs isolated with the ISOGEN (Nippon gene) from embryos at appropriate stages and of each genotype was subjected to the RT-PCR analysis, using Advantage RT-for-PCR (Clontech), according to the protocol provided by the manufacturer. The purity and quantity of cDNAs were analyzed with Hprt specific primers. Primers used to detect each gene transcript and lengths of amplified products are: RT-S1, 5′-TGGCTACAGACCAGTG-CAGC-3′; RT-S2, 5′-GGAGACACACACAGACACGC-3′; RT-H1, 5′-AGG-TTGCAAGCTTGCTGG-3′; RT-H2, 5′-GTAGGCTGGCCTATAGGCTC-3′. The locations for each primer are indicated in the construction figure (Fig.  6A ). Northern blot analysis was conducted with total RNAs isolated from each genotype of E9.5 embryos using a probe covering mShisa exon 2 and 3′ UTR as previously described (Sambrook et al., 1989) .
Skeletal analysis
Cartilage and bones were stained with alcian blue and alizarin red as described (Kelly and Bryden, 1983; Hide et al., 2002) .
Assays with Xenopus embryos and Hek293T cells
Frog care, fertilization, and embryonic culture were carried out as described (Sive et al., 2000) . mRNA injection into Xenopus embryos and animal cap assay were performed as described (Yamamoto et al., 2005; Nagano et al., 2006) . Luciferase assay with Hek293T cells was also performed as described (Yamamoto et al., 2005; Nagano et al., 2006) . To detect cellular localization of the mShisa gene product, the open reading frame was subcloned into pCS2 (mShisa/pCS2) and HA-tag sequence was added to the C-terminals of the coding sequences by PCR, yielding mShisa-HA/pCS2.
Results
Mouse orthologue of Xenopus Shisa1 as a potential Otx2 target
The Otx2 expression in anterior neuroectoderm at presomite and early somite stage is regulated by an enhancer designated as AN that is located at about 90 kb upstream of the translation start site (Kurokawa et al., 2004) . In the mutant that lacks this enhancer, Otx2 ΔAN/− , Six3-positive anterior neuroectoderm initially develops but is subsequently caudalized into Gbx2-positive posterior neuroectoderm by E9.5. In our attempt to isolate Otx2 targets in mouse anterior neuroectoderm that antagonize the caudalization, a microarray analysis was performed with E7.5 Otx2 ΔAN/+ and Otx2 ΔAN/− embryos. The analysis identified a gene which is expressed in anterior visceral endoderm at E6.5 (Fig. 1A ) and in anterior mesendoderm and anterior neuroectoderm at E7.75 (Figs. 1C-E) . Moreover, its expression in visceral endoderm was absent in Otx2 −/− embryos at E6.5 (Fig. 1B) . That in anterior mesendoderm and anterior neuroectoderm of Otx2 ΔAN/− embryos was variable, but in the majority of embryos it was greatly reduced at E7.75 (Fig. 1F ).
Sequence analysis of this clone demonstrated that the gene is a mouse homologue of Xenopus Shisa (xShisa1) ( Fig. 1G ; Yamamoto et al., 2005) ; we designated it mShisa.
mShisa homologues
The mShisa open reading frame consists of 295 amino acids (Fig. 1E) ; it has a signal peptide and two cysteine-rich domains (CRD1 and CRD2) in the amino-terminal half as xShisa1 does (in Fig. 1H ). BLAST search (http://www.ncbi.nlm.nih.gov/ BLAST/) with the mShisa cDNA sequence showed three other paralogues in mouse; they were designated as mShisa3, mShisa4 and mShisa5 (see below). In Xenopus there are three genes paralogous to xShisa1; they were designated as xShisa2, xShisa3 and xShisa4 (Nagano et al., 2006: Yamamoto et al., unpublished data) . Phylogenetic analysis demonstrated mShisa to be the closest to xShisa2 (Fig. 2) . Recently, Shisa homologues were also reported in human, rat and chick (hShisa, rShisa and cShisa) (Katoh and Katoh, 2005) ; they also belong to the Shisa2 subfamily. Zebrafish has a Shisa1 orthologue, but amniotes appear to lack Shisa1 orthologues. mShisa3 and mShisa4 are orthologous to xShisa3 and xShisa4, respectively. Orthologues to each of these subfamilies appear to exist in all amniotes. Zebrafish lacks a Shisa3 orthologue; a Shisa4 orthologue is not found in the chick genome data available. mShisa5 is Scotin identified as a downstream molecule of p53 in cultured cells (Bourdon et al., 2002) . Xenopus lacks this orthologue, while the orthologue apparently underwent multiplication in zebrafish. In summary, there are five Shisa paralogues, but each vertebrate might lack one of them. No Shisa homologues are found in Ciona intestinalis, Caenorhabditis elegans or Drosophila melanogaster genome.
Expression of mShisa, mShisa3, mShisa4 and mShisa5
It was puzzling that mShisa is closer to xShisa2 than xShisa1 since in Xenopus it is xShisa1 that is expressed in deep endoderm cells at pregastrulation and in anterior mesendoderm and anterior neuroectoderm during gastrulation (Yamamoto et al., 2005) . xShisa2 is never expressed in these tissues; it is unique in somitic mesoderm (Nagano et al., 2006) . Therefore, the expression of each mouse Shisa was compared at each stage of mouse embryo by RNA in situ hybridization.
The mShisa expression was faintly found at E5.5 in distal visceral endoderm (data not shown) and became obvious at E6.5 in the most anterior part of visceral endoderm (Fig. 1A) . At E6.5 mShisa5 expression was weakly detected in extraembryonic ectoderm (Fig. 4K ), but neither mShisa3 nor mShisa4 expression was apparent (Figs. 4A, F). At E7.0 the mShisa expression spread over the anterior visceral endoderm and occurred in the anterior ectoderm ( Fig. 3A) . At E7.75 mShisa was expressed in definitive anterior endoderm, anterior mesoderm and anterior neuroectoderm as described above (Figs. 1C-E). The mShisa5 expression was apparent in chorion and weakly in yolk sac (Fig. 4L ), but neither mShisa3 nor mShisa4 expression was found at E7.5 (Figs. 4B, G). At E8.25 when the headfold is formed, the mShisa expression was evident in the forebrain and foregut (Figs. 3B, C). In addition, the expression occurred in segmented somites; a low level of the expression was also seen in the presomitic mesoderm ( Fig. 3B ). At E8.5, mShisa3 expression took place in foregut (Fig. 4C) , and at E8.0, mShisa5 expression was also apparent in foregut and yolk sac (Figs. 4M, N) . No mShisa4 expression was observed in any sites (Fig. 4H) . At E9.5, in addition to forebrain and somitic mesoderm, the mShisa expression was found in surface ectoderm of anterior forebrain region, head mesenchyme, pharyngeal mesenchyme, ventral hindbrain, and otic cup; it was weakly expressed in mesonephric tubules (Fig. 3D , and data not shown). The mShisa expression in forebrain was restricted to telencephalon. The expression in mesenchyme in the pharyngeal region took place at E9.0 (data not shown), but did not extend into pharyngeal pouches (Fig. 3D) . At E12.5, mShisa expression was detected in cerebrum cortex, lateral ganglionic eminences, preoptic area neuroepithelium, hypothalamus, ventral part of otic placode including adjacent mesenchyme, a part of tongue, endocardial cushion around aortic valve, myotome and muscle primordia (Figs. 3E-H) .
At E9.5 mShisa3 expression in foregut expanded (Fig. 4D) ; it was prominent in hepatic primordium, the nephric duct rudiment and the ventral portion of somites. The exclave-like expression was also found in ventral mesencephalon and (Thompson et al., 1994 ; DDBJ analyzing program, http://www.ddbj.nig.ac.jp/search/clustalw-j.html) using amino acid sequence of mShisa (Fig. 1G) , mShisa3 (AK077061), mShisa4 (AK039457) and mShisa5 (AK033545) for mouse homologues, hShisa (NM001007538), hShisa3 (XM941105), hShisa4 (BC104445) and hShisa5 (NM016479) for human homologues, cShisa (NM204501), cShisa3 (BX933586) and cShisa5 (NM001030591) for chick homologues, xShisa1 (AY579372), xShisa2 (CF286494), xShisa3 (BI449671) and xShisa4 (AB242599) for Xenopus homologues, and zShisa1 (NM001003631), zShisa2 (XM_689865), zShisa4 (XM_696718), zShisa5a (XM_700002), zShisa5b (XM_681926) and zShisa5c (XM_681848) for zebrafish homologues. rhombencephalon (arrows in Fig. 4D) ; at E10.5 it was expanded over the ventral midbrain and hindbrain except for isthmus (data not shown). At E12.5 the mShisa3 expression was found in the ventral part of midbrain, kidney and myotome (Fig. 4E) . No mShisa4 or mShisa5 expression was found at E9.5 (Fig. 4I , data not shown) or E10.5 (data not shown). At E14.5, mShisa4 transcripts were detected in the spinal cord, dorsal root ganglia, lung and muscle in the limb (Fig. 4J) ; it was also found in ventricular zone of brain, retina, and trigeminal ganglia (data not shown).
In summary, mShisa expression mostly covers the sites of both xShisa1 and xShisa2 expression in Xenopus. However, the expression in mouse forebrain is prolonged at stages later than xShisa1 expression in Xenopus anterior neuroectoderm. mShisa expression is present in aortic arch, but neither xShisa1 nor xShisa2 expression exists at this site. xShisa3 is expressed in isthmus where Fgf and Wnt signalings function; however, none of the mouse Shisa paralogues was expressed in the isthmus. Otherwise the mShisa3 expression pattern was similar to the xShisa3 expression; xShisa4 expression is also not apparent during early embryogenesis (our unpublished result).
mShisa inhibits both Wnt and Fgf signaling
We previously reported that xShisa1 and xShisa2 gene products inhibit both Wnt and Fgf signaling cell-autonomously, regulating head and somite development in Xenopus (Yamamoto et al., 2005; Nagano et al., 2006). They do not affect Nodal or BMP signaling. It was then examined whether the mShisa gene product (mShisa) also functions as a Wnt and Fgf antagonist. In Xenopus embryos mShisa overexpression expanded Otx2-positive anterior neuroectoderm at stage 14, and head and cement gland at stage 23 as xShisa1 overexpression does (Figs. 5A-D) . In the animal cap assay, the xWnt8 ectopic expression or the treatment with basic Fgf (Fgf2) protein induces the Xnr3 and Xbra expressions, respectively (Brannon et al., 1997; McKendry et al., 1997; Pownall et al., 1996) . mShisa expression inhibited these in a dose-dependent manner, as xShisa1 does (Figs. 5E, F) . mShisa neither induced neuroectoderm in animal caps nor a secondary axis on the ventral side. Moreover, mShisa inhibited the Xbra expression, but not Mix2 expression, by Activin (Fig. 5G) . These results suggest that mShisa also uniquely inhibits both Wnt and Fgf signaling.
mShisa does not encode a known ER (endoplasmic reticulum) retention signal as also true of xShisa1. In Hek293T cells, however, HA-tagged mShisa colocalized with an ER marker (Figs. 5H-K) . We also examined the mode of mShisa action in the Wnt signaling with Hek293T cells. Ligand cells expressing Wnt3a and receptor cells expressing mFrizzled8 (Fz8) and Lrp6 together with TOPFLASH reporter (Korinek et al., 1997) were prepared independently and cocultured for Wnt signaling stimulation. Wnt3a elevated the reporter activity non-cell-autonomously about fifteen-fold (Fig. 5L). In this assay mShisa expression in ligand cells did not affect the reporter activity; however, mShisa expression in the receptor cells suppressed the reporter activity below the basal level, demonstrating that mShisa inhibits Wnt signaling cellautonomously in the receptor cells.
Targeted disruption of mShisa, mShisa3, mShisa4 and mShisa5
To assess each Shisa gene function in mouse embryogenesis, we generated mouse mutants. To disrupt mShisa, a 885 bp fragment spanning from the NotI site at 540 bp upstream of the translation start site to a part of the succeeding intron was replaced with a lacZ-neo cassette (Murata et al., 2004, Fig. 6A ).
The mShisa first coding exon encodes the signal peptide and first cysteine-rich domain (Fig. 1G) , which is essential for the xShisa1 function (Yamamoto et al., 2005) . In heterozygous mouse embryos (mShisa +/lacZ ) βGal was expressed in the pattern that faithfully recapitulated mShisa mRNA expression at E6.0, E7.0, E7.75, E8.25 and E9.5 (Fig. 6E) . mShisa +/lacZ mice were then intercrossed to examine homozygous (mShisa lacZ/lacZ ) phenotype. mShisa is expressed in anterior visceral endoderm, anterior mesendoderm, anterior neuroectoderm and somatic mesoderm as noted above. However, homozygous mutant embryos developed Cerberus-like (Cerl) positive anterior visceral endoderm (Fig. 6F) , Cerl-and Otx2-positive anterior mesendoderm (Figs. 6G-I ) and Otx2-positive anterior neuroec- toderm (Figs. 6H, I ), and Pax6-positive forebrain (Fig. 6J ) apparently normally. At E12.5 each structure of brain, ganglionic eminences, hypothalamus, neocortex, archicortex, prethalamus, mammillary region, thalamus, pretectum, tegmentum and pons, was histologically normal (Figs. 6K, L); nor were any defects apparent in somitogenesis (Figs. 6K, M) . RT-PCR analysis at the second coding exon as well as that over the first and second coding exons and Northern analysis of E9.5 mShisa lacZ/lacZ whole embryos indicated the null nature of the mutant (Fig. 6D, data not shown) .
Homozygous mutant mice were live-born in a Mendelian ratio after heterozygous-heterozygous mating. About one-third of the homozygous mutants were normal and fertile, but about two-thirds of the homozygous mutants (38/54) were dwarf. Reduction in weight gain became apparent at the postnatal third week; about half of the dwarf mice subsequently resumed the weight increase, although they remained dwarf; the others died within a month after birth ( Supplementary Fig. 1A ). The food consumption ratio per body weight in the dwarf and non-dwarf mice was comparable. Fgf and Wnt signalings are essential in bone development (Wilkie, 2005; Baron et al., 2006) , but alizarin red and alcian blue staining of severely dwarf mutant skeleton showed no apparent defects. Pituitary was also histologically normal (Supplementary Figs. 1F, G) , but dying dwarf mice exhibited malformation of the thalamus with an expansion of the space between cerebrum and thalamus ( Supplementary Figs. 1B-E) . The malformation was not apparent in dwarf mutants surviving beyond 1 month. Defects in forebrain development can lead to defects in the thalamus, and this in turn to dwarfism. The cause of the dwarfism in homozygous mutants, however, awaits further study.
mShisa3 mutant was also generated by replacing a 437 bp sequence spanning 176 bp upstream of the translation initiation site to a part of the succeeding intron with the lacZ-neo cassette ( Supplementary Fig. 2A) ; the deleted exon encodes the signal peptide and first cysteine-rich domain. In the E9.5 heterozygous embryos, βGal expression captured the endogenous mShisa3 expression only partially (Fig. 4D, Supplementary Fig. 2Ga ). mShisa4 gene was disrupted by replacing a 128 bp sequence spanning 49 bp upstream of the translation initiation site to a part of the succeeding intron with the lacZ-neo cassette ( Supplementary Fig. 2B ). The deleted coding exon encodes the signal peptide. The heterozygous mutant displayed βGal expression in E14.5 forelimb and hindlimb ( Supplementary Fig.  2Gb ), where endogenous mShisa4 expression was confirmed Two open boxes indicate coding exons, which are marked with the initiation codon (ATG) and termination codon (STOP), respectively (wild allele). In the targeting vector the first coding exon and a part of the succeeding intron was replaced with the lacZ-neo cassette; the vector has 7.8 kb 5′ and 4.0 kb 3′ homologous arms. Control vector with 5.8 kb 3′ homologous arm was used to set up PCR condition for the identification of homologous recombinant ES clones (Murata et al., 2004) . The locations of the PCR primers are indicated by arrows designated as S1-5 and S1-3. by mRNA in situ hybridization (Fig. 4J) . However, several discrepancies were apparent between the βGal expression and endogenous mShisa4 expression, the details of which remain to be determined. mShisa5 has two isoforms by alternative splicing (Watahiki et al., 2004 ; NCBI BLAST information). The last three coding exons are common to both isoforms: they are the 4th to 6th exons in the long isoform and the 2nd to 4th exons in the short isoform. The exons encode the C-terminal amino acids including CRD2. Consequently, these three exons down to the 11 bp of the stop codon, together with intervening introns, were replaced with an IRES-lacZ-neo cassette (Furushima et al., 2005) (Supplementary Fig. 2C ); no βGal expression was detected in E7.0 or E8.5 heterozygous embryos (data not shown).
Three mutant mouse lines were established from independent homologous recombinant ES clones on each Shisa gene. All these mShisa3, mShisa4 and mShisa5 single mutants gave rise to apparently normal and fertile homozygous pups in Mendelian ratio after heterozygous-heterozygous crosses. mShisa deficiency is apparently not compensated by either mShisa3, mShisa4 or mShisa5
Our primary interest is in the functions of mShisa in anterior visceral endoderm, anterior mesendoderm and anterior neuroectoderm. Neither mShisa3, mShisa4 nor mShisa5 is expressed in these tissues. Nevertheless, no defects were apparent in mShisa lacZ/lacZ mutant. A compensatory expression of either of these paralogues could be questioned in the mShisa lacZ/lacZ mutant. However, none of mShisa3, 4 or 5 was expressed in either anterior visceral endoderm (Figs. 7A, Therefore Dkk1 is the best candidate of a compensatory molecule for mShisa deficiency in anterior visceral endoderm and anterior mesendoderm. A Dkk1 mutant was then generated by replacing a 796 bp sequence, from 71 bp upstream of the translation initiation site to 122 bp downstream of the second coding exon, with Venus-PGKneo (Supplementary Fig. 2D ). In this heterozygous mutant, Dkk1 +/venus , fluorescent Venus expression traced the endogenous Dkk1 expression in anterior visceral endoderm at E6.5, anterior mesendoderm at E7.5 and forebrain, foregut, heart and paraxial mesoderm at E8.5 ( Supplementary Fig. 2H ).
Dkk1 venus/venus homozygous mutants develop anterior visceral endoderm normally at E6.5. However, development of anterior neuroectoderm is affected, though variably, at E7.5; this is most probably due to Dkk1 deficiency in anterior mesendoderm, as was previously reported by Mukhopadhyay et al. (2001) . The Dkk1 and mShisa double mutant, Dkk1 venus/venus mShisa lacZ/lacZ , phenotype exhibited no remarkable differences to that of the Dkk1 single mutant; there was no Dkk1/mShisa double mutant that was more severe than the severest Dkk1 single mutant. In the most severe double mutant Cerl-positive anterior visceral endoderm and anterior mesendoderm were normally formed at E6.5 and E7.25 (Figs. 7G, H) , and Otx2-positive anterior neuroectoderm was also induced at E7.75 (Fig. 7I) . However, Six3-positive anterior neuroectoderm was lost at E8.5 (data not shown) and Pax6-positive forebrain was absent at E9.5 (Fig. 7J) .
Sfrp1 encodes a Wnt antagonist also expressed in anterior visceral endoderm, anterior mesendoderm and anterior neuroectoderm (Hoang et al., 1998; Leimeister et al., 1998; Kemp et al., 2005) . Its expression in anterior visceral endoderm is reduced, though not completely lost, in Otx2 −/− mutants (data not shown). Then, mShisa double mutants with Sfrp1 mutants (Satoh et al., 2006) were also generated. However, the double mutants exhibited no defects in the development of Cerlpositive anterior visceral endoderm (data not shown) and anterior mesendoderm (Fig. 7K ) and Otx2-positive anterior mesendoderm and anterior neuroectoderm (Fig. 7L ).
Cerl and Cerl-2 encode multifunctional antagonists against Nodal, BMP and Wnt signalings. They are expressed in the anterior visceral endoderm, anterior mesendoderm and/or node (Belo et al., 1997; Piccolo et al., 1999; Marques et al., 2004) ; they are expressed in these tissues of Otx2 −/− embryos (data not shown, Kimura et al., 2001) . We also examined mShisa lacZ/lacZ Cerl −/− and mShisa lacZ/lacZ Cerl-2 −/− double mutant phenotypes, but no defects were found in anterior neuroectoderm development of these double mutants either (data not shown). Lefty1 and Lefty2 encode Nodal antagonists expressed in anterior visceral endoderm, anterior mesendoderm and/or node (Meno et al., 1996 (Meno et al., , 1999 . mShisa lacZ/lacZ Lefty1 −/− or mShisa lacZ/lacZ Lefty2 −/− double mutants also exhibited no defects in anterior neuroectoderm development (data not shown).
Discussion
The Shisa family of genes is classified into five subfamilies, assigning mShisa to the Shisa2 subfamily. Amniotes appear to lack Shisa1 orthologues; Xenopus and zebrafish that have this subfamily are animals that underwent tetraploidization or whole genome duplication Postlethwait et al., 1998) . In Xenopus xShisa1 is expressed in head organizer tissues (deep endoderm cells at pregastrulation and anterior mesendoderm at gastrulation) and anterior neuroectoderm, and xShisa2 in somitic mesoderm. In mouse mShisa is expressed in all these tissues. Thus, a Shisa gene that was orthologous to mShisa, hShisa and cShisa in ancestral Amphibia might have been duplicated into xShisa1 and xShisa2, leading to the segregation of each expression into either of these two genes as the geneduplication-complementation-degeneration model expects (Force et al., 1999) . The expression pattern of zShisa1 and zShisa2 that might have been generated by an independent duplication remains to be determined. No Shisa homologues are found in either C. intestinalis, D. melanogaster or C. elegans genome; the Shisa family of genes is probably unique to vertebrates.
mShisa was identified as a gene of which expression was greatly reduced in Otx2 ΔAN/− anterior neuroectoderm; its expression is completely lost in Otx2 −/− anterior visceral endoderm. Probably there exists another enhancer for the Otx2 expression in anterior neuroectoderm (Kurokawa et al., 2004 ). There remains a low level Otx2 expression in Otx2 ΔAN/− anterior neuroectoderm (our unpublished data); this may account for the variation, at a very low level, of mShisa expression in this ectoderm. These suggest that mShisa is an Otx2 target, but it remains to future studies whether mShisa expression is directly regulated by Otx2. We have examined a 14 kb mShisa genomic region from 8 kb 5′ upstream of the translation start codon to the 1.4 kb 3′ downstream of the termination codon for transcriptionregulatory sequences. However, this region has no enhancers responsible for the mShisa expression in anterior visceral endoderm, anterior mesendoderm or anterior neuroectoderm.
Functional studies in Xenopus have suggested that mShisa encodes a head inducer that inhibits Wnt and Fgf signalings as xShisa1 and xShisa2 do. Studies in Hek293T cells have also suggested that mShisa functions cell-autonomously in endoplasmic reticulum as xShisa1 and xShisa2 do. In the reticulum xShisa1 and xShisa2 suppress the maturation and cell surface expression of Frizzled and Fgf receptor. However, in contrast to defects in head formation and somitogenesis by xShisa1 and xShisa2 morpholino in Xenopus (Yamamoto et al., 2005; Nagano et al., 2006) , mShisa mouse mutants exhibited no phenotype in either head development or somitogenesis. mShisa3, mShisa4 or mShisa5 single mutants also exhibited no apparent phenotype. Attention should be paid to the physiological significance of phenotypes brought about by morpholino or siRNA treatment. In contrast to the critical functions observed in Xenopus and/or zebrafish, no defects have been observed in mouse mutants for many genes, especially for signal antagonists, expressed in head organizer tissues (anterior visceral endoderm and anterior mesendoderm): Noggin, Chordin, Cerl, Cerl-2, Lefty1 and Sfrp1. Among signal antagonists in head organizer tissues, Dkk1 is the only gene of which single mutation exhibited head truncation; the defect is most probably by the loss of Dkk1 function in anterior mesendoderm, and no defects are apparent by its loss in anterior visceral endoderm (Mukhopadhyay et al., 2001) .
In many cases no phenotype in a gene KO is explained by complementary functions of paralogous genes. Sfrp1 or Sfrp2 single mutants do not exhibit but their double mutants display defects in somitogenesis (Satoh et al., 2006) . However, normal head formation in mShisa mutants is unlikely to be explained in terms of the compensation by mShisa3, mShisa4 or mShisa5. None of these genes is expressed in head organizer tissues; nor is their expression induced in these tissues of mShisa mutants. Furthermore, mShisa double mutants with any of these genes exhibited no defects in head formation. Normal head development in single mutants of other signal antagonists expressed in head organizer tissues has also not been explained in terms of the compensation by other members of the same family. In the Sfrp family, Sfrp1 and Sfrp5 are expressed in anterior visceral endoderm, but their double mutants exhibit no defects in head development (Shimono et al., unpublished data) .
Another cause of the normal phenotype in a gene knockout is the compensation by a gene that is structurally unrelated but functionally closely related. Chordin and Noggin are structurally unrelated but both function as secreted BMP antagonists. Chordin and Noggin single mutants develop forebrain normally but their double mutants exhibit failure in forebrain development (McMahon et al., 1998; Bachiller et al., 2000) . Cerl and Lefty1 are Nodal antagonists. Single mutants do not, but their double mutants exhibit defects in primitive streak formation (Perea-Gomez et al., 2002) .
Fgf antagonists that are expressed in head organizer tissues and could be functionally related with mShisa are not known, but there are many Wnt antagonists that are expressed in head organizer tissues. However, no complementary functions among these Wnt antagonists have been demonstrated yet in mouse head development. Anterior visceral endoderm and anterior mesendoderm express mShisa, Dkk1, Sfrp1 and Sfrp5, while anterior neuroectoderm expresses mShisa, Sfrp1, Sfrp2 and Sfrp3 (Hoang et al., 1998; Leimeister et al., 1998; Kemp et al., 2005) . We had especially expected the complementary functions between mShisa and Dkk1 since their expressions are both lost in anterior visceral endoderm of Otx2 −/− mutants. However, no defects were apparent in head development by the simultaneous loss of their functions in anterior visceral endoderm. Nor were defects in head development observed in mShisa/Sfrp1 double mutants. The phenotype of triple and quadruplex mutants among mShisa1, Dkk1, Sfrp1 and Sfrp5 remains to be examined. The cooperation among mShisa, Sfrp1, Sfrp2 and Sfrp3 in anterior neuroectoderm also remains to be examined yet by their triple and quadruplex mutations. In addition, the possibility exists that there is an unidentified Wnt antagonist that functions in head organizer tissues and/or anterior neuroectoderm, cooperating with mShisa.
The possibility might also be kept in mind that mShisa cooperates with antagonists in Nodal and BMP signalings where mShisa does not function. Dkk1 single heterozygotes or Noggin single homozygotes do not, but their double mutants (Dkk1 +/− /Noggin +/− and Dkk1 +/− /Noggin −/− ) exhibit defects in head development (del Barco Barrantes et al., 2003) . However, neither mShisa/Cerl, mShisa/Cerl-2, mShisa/Lefty1 nor mShisa/Lefty2 double mutants exhibited such defects. mShisa/ Noggin and mShisa/Chordin double mutant phenotypes remain to be examined.
One question that arises is why so many antagonists, particularly Wnt antagonists, are needed in head organizer tissues to limit signaling. Interestingly, Chordin is the only signaling antagonist in vertebrate head organizers that has an invertebrate homologue; Shisa, Sfrp, Dkk, Cer, Lefty and Noggin are all unique to vertebrates. It may be that the many antagonists serve to fine-tune the process of head development. In this model, the process is able to proceed, although less smoothly, even in the absence of these tuning mechanisms, although the present level of analysis is unable to detect these putative subtle perturbations.
